Search

Mies van der Rohe Foundation Launches Lilly Reich Grant for Equality in Architecture

MIES VAN DER ROHE FOUNDATION LAUNCHES LILLY REICH GRANT FOR EQUALITY IN ARCHITECTURE

© Pepo Segura The Mies van der Rohe Foundation has launched the second edition of the Lilly Reich Grant for equality in architecture....

ELI LILLY'S R&D REVOLVING DOOR SPINS AGAIN AS GANDHI HEADS BACK TO DANA-FARBER

Eli Lilly's R&D revolving door spins again as Gandhi heads back to Dana-Farber badams Mon, 06/15/2020 - 10:21

 
 
 
COVID-19 has been deadlier for Black communities in Brazil and the US, thanks to shared legacies of slavery and systemic racism

COVID-19 HAS BEEN DEADLIER FOR BLACK COMMUNITIES IN BRAZIL AND THE US, THANKS TO SHARED LEGACIES OF SLAVERY AND SYSTEMIC RACISM

REUTERS/Bruno Kelly Kia Lilly Caldwell is a professor of African, African American, and diaspora studies at the University of North...

LILLY PENS ANTISENSE NEURO PACT WITH EVOX THERAPEUTICS

Lilly pens antisense neuro pact with Evox Therapeutics badams Wed, 06/10/2020 - 05:40

 
 
 
Matrix 4's ‘Beautiful Script' Credited for Keanu Reeves & Carrie-Anne Moss' Return

MATRIX 4'S ‘BEAUTIFUL SCRIPT' CREDITED FOR KEANU REEVES & CARRIE-ANNE MOSS' RETURN

Matrix 4's ‘Beautiful Script' Credited for Keanu Reeves & Carrie-Anne Moss' Return During an interview with Empire , The Matrix franchise...

LILLY STARTS SECOND COVID-19 ANTIBODY TEST WITH PARTNER JUNSHI BIOSCIENCES, EYES COMBO TRIALS

Lilly starts second COVID-19 antibody test with partner Junshi Biosciences, eyes combo trials badams Mon, 06/08/2020 - 12:04

 
 
 
The Matrix's Lilly Wachowski Explains Her Departure From Hollywood

THE MATRIX'S LILLY WACHOWSKI EXPLAINS HER DEPARTURE FROM HOLLYWOOD

The Matrix's Lilly Wachowski Explains Her Departure From Hollywood During an interview with The Hollywood Reporter , filmmaker and...

Chinook, Aduro Merger Plan Sets Up New Kidney Disease-Focused Biotech

CHINOOK, ADURO MERGER PLAN SETS UP NEW KIDNEY DISEASE-FOCUSED BIOTECH

Chinook Therapeutics and Aduro Biotech, each pursuing different approaches to the same rare disease, are now converging on a path to...

 
 
 
Forma Therapeutics Eyes IPO to Advance Sickle Cell, Prostate Cancer Drugs

FORMA THERAPEUTICS EYES IPO TO ADVANCE SICKLE CELL, PROSTATE CANCER DRUGS

Forma Therapeutics has developed a pipeline of small molecules aimed at rare blood disorders and cancers, but it aims to advance two-investigational...

FDA Welcomes Variety of Phase 2/3 Trial Designs for COVID-19 Therapies

FDA WELCOMES VARIETY OF PHASE 2/3 TRIAL DESIGNS FOR COVID-19 THERAPIES

The US FDA's formal guidance on development of COVID-19 treatments and preventative agents takes a broadly flexible approach to Phase...

 
 
 

THE MONEY KEEPS COMING FOR ELI LILLY COVID-19 PARTNER ABCELLERA WITH $105M ROUND

The money keeps coming for Eli Lilly COVID-19 partner AbCellera with $105M round badams Wed, 05/27/2020 - 05:28

 
 
 
‘Take the red pill': Elon Musk sends Twitter into Matrix meltdown, gets Ivanka Trump's praise. & ‘f*** you both' from Wachowski

‘TAKE THE RED PILL': ELON MUSK SENDS TWITTER INTO MATRIX MELTDOWN, GETS IVANKA TRUMP'S PRAISE. & ‘F*** YOU BOTH' FROM WACHOWSKI

Elon Musk has yet again triggered an online storm, urging the public to “take the red pill.” The Matrix reference got him showered...

‘Matrix' Co-Creator Tweets ‘F*ck Both of You' at Elon Musk and Ivanka Trump After ‘Red Pill' Tweets

‘MATRIX' CO-CREATOR TWEETS ‘F*CK BOTH OF YOU' AT ELON MUSK AND IVANKA TRUMP AFTER ‘RED PILL' TWEETS

Win McNamee/Getty Images Tesla and SpaceX CEO Elon Musk had another weird day on Twitter Sunday, drawing an F-bomb rebuke from the...

 
 
 
Bio Roundup: FDA Dings BMS, Genfit's Fall, Alexion's Activist & More

BIO ROUNDUP: FDA DINGS BMS, GENFIT'S FALL, ALEXION'S ACTIVIST & MORE

This was a disappointing week for at least two major drug makers. French firm Genfit reported a trial failure in an intensely competitive...

‘A Little Late with Lilly Singh' renewed for Season 2 by NBC

‘A LITTLE LATE WITH LILLY SINGH' RENEWED FOR SEASON 2 BY NBC

Production is currently on hold due to the coronavirus pandemic.

 
 
 
Eli Lilly Gets Edge in the “RET” Race With FDA Nod for Cancer Drug

ELI LILLY GETS EDGE IN THE “RET” RACE WITH FDA NOD FOR CANCER DRUG

Eil Lilly received accelerated FDA approval Friday for a drug that treats advanced cancers carrying a certain genetic signature. It's...

AstraZeneca Diabetes Drug Gets FDA OK for Reducing Heart Health Risks

ASTRAZENECA DIABETES DRUG GETS FDA OK FOR REDUCING HEART HEALTH RISKS

An AstraZeneca diabetes drug that brought in more than $1.5 billion in sales last year has won an FDA nod expanding its use to adults...

 
 
 

COVID-19: LILLY RAMPS UP TO BEAT THE VIRUS WITH NEUTRALIZING ANTIBODIES AS SCIENTISTS RAISE WORRIES

Eli Lilly has teamed with China's Junshi Biosciences in the U.S., marking the company's second COVID-19 pact to develop neutralizing...

LILLY: RESEARCH SCIENTIST-MEDICINAL CHEMISTRY

Competitive: Lilly: For more than 140 years, Eli Lilly has been dedicated to meeting the health care needs of people around the world....